# Response to the Letter to the Editor Entitled “Optimizing Furosemide Use in Advanced CKD: Balancing Risks and Benefits”

**Authors:** M. Costes-Albrespic, N. Alencar de Pinho, Z.A. Massy, S. Liabeuf

PMC · DOI: 10.1016/j.ekir.2025.05.048 · 2025-06-03

## Full-text entities

- **Diseases:** CKD (MESH:D012080)
- **Chemicals:** Furosemide (MESH:D005665)

---
Source: https://tomesphere.com/paper/PMC12348217